 LOWELL, Mass., Aug. 04, 2021 GLOBE NEWSWIRE -- Rapid Micro Biosystems, Inc. Nasdaq: RPID Rapid Micro, an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the underwriters of its previously announced initial public offering of Class A common stock have exercised their option to purchase additional shares in part for 1,086,604 shares at the public offering price of 20.00 per share less underwriting discounts and commissions, for additional gross proceeds to Rapid Micro of 21.7 million. The exercise of the over-allotment option closed on August 4, 2021. 